Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tang-Kai Cheng

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Rheumatic Diseases|July 6, 2026
Bridging the Gap in Hydroxychloroquine Monitoring for SLE: Evidence, Limitations, and Future DirectionsTang-Kai Cheng, James Cheng-Chung Wei
International Journal of Rheumatic Diseases|November 21, 2025
Targeting IL-1 in Autoinflammatory Syndromes: Lessons From Canakinumab and VEXAS SyndromeTang-Kai Cheng, Hung-Ke Lin, Ping Zeng
International Journal of Rheumatic Diseases|May 17, 2026
The JAK Inhibitor Paradox: A Mechanistic Divide Between Adaptive and Innate ImmunityHung-Ke Lin, Tang-Kai Cheng, Meng-Che Wu
International Journal of Rheumatic Diseases|May 16, 2026
Treating Gout to Target: Protecting the Heart From the First Flare to Long-Term ControlRobert T Keenan, Tang-Kai Cheng, James Cheng-Chung Wei
International Journal of Rheumatic Diseases|June 5, 2026
Deconstructing the Synovium: A New Era of Precision Medicine in Rheumatoid ArthritisTang-Kai Cheng, Wei-Che Hsu, James Cheng-Chung Wei
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Rheumatic Diseases|July 6, 2026
Bridging the Gap in Hydroxychloroquine Monitoring for SLE: Evidence, Limitations, and Future DirectionsTang-Kai Cheng, James Cheng-Chung Wei
International Journal of Rheumatic Diseases|November 21, 2025
Targeting IL-1 in Autoinflammatory Syndromes: Lessons From Canakinumab and VEXAS SyndromeTang-Kai Cheng, Hung-Ke Lin, Ping Zeng
International Journal of Rheumatic Diseases|May 17, 2026
The JAK Inhibitor Paradox: A Mechanistic Divide Between Adaptive and Innate ImmunityHung-Ke Lin, Tang-Kai Cheng, Meng-Che Wu
International Journal of Rheumatic Diseases|May 16, 2026
Treating Gout to Target: Protecting the Heart From the First Flare to Long-Term ControlRobert T Keenan, Tang-Kai Cheng, James Cheng-Chung Wei
International Journal of Rheumatic Diseases|June 5, 2026
Deconstructing the Synovium: A New Era of Precision Medicine in Rheumatoid ArthritisTang-Kai Cheng, Wei-Che Hsu, James Cheng-Chung Wei
Pageof 1